Sormani MP, Häring DA, Kropshofer H, et al. Blood NfL as a potential endpoint in Phase 2 clinical studies in relapsing-remitting multiple sclerosis. ECTRIMS 2017, 277.
ECTRIMS 2015 video update Teunissen: Progressive MS - how do we meet the therapeutic challenge?
jun 2017